Associated Papers
Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans.
Gnatenko DV et al.
Blood Advances, 2022
35381074 (PubMed )
Supplement: advancesADV2021005648-suppl1.pdf
Genetic variability in COVID-19-related genes in the Brazilian population.
Secolin R et al.
Human Genome Variation, 2021
33824725 (PubMed )
Supplement: 41439_2021_146_MOESM3_ESM.xlsx › In_silico_prediction_results
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure.
Hansen PR et al.
The Pharmacogenomics Journal, 2019
Clonal analyses of refractory testicular germ cell tumors.
Barrett MT et al.
Plos One, 2019
Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues.
Dehghani M et al.
Frontiers in Molecular Biosciences, 2019
31681791 (PubMed )
Supplement: Data_Sheet_14.XLSX › SNV_and_indels
Whole-Exome Sequencing Study of Extreme Phenotypes of NAFLD.
Kleinstein SE et al.
Hepatology Communications, 2018
Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor.
Curtin K et al.
Bmc Medical Genetics, 2010
Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.
Carr DF et al.
Pharmacogenetics and Genomics, 2007
IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort.
Liu Y et al.
Journal of the American Society of Nephrology : Jasn, 2006
Interleukin-6 sequence variants are not associated with prostate cancer risk.
Sun J et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2004
The impact of "high-producer" interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population.
Krüger B et al.
Transplantation Proceedings, 0
Select a paper to view details